跳至主要内容
临床试验/NCT01338766
NCT01338766Unknown不适用

Spondylolisthesis Treated With an iO-Flex® System Enabled Decompression (STRiDE)

Baxano Surgical, Inc.28 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
28
主要终点
Oswestry Disability Index (ODI)

研究概览

简要总结

The purpose of this study is to evaluate the clinical performance of a decompression using the FDA cleared iO-Flex® System on-label in treating patients with spinal stenosis and stable grade I degenerative lumbar spondylolisthesis using a precision estimate assuming a 55% positive response rate.

详细描述

This is a prospective, non-randomized, multi-center (up to 30 sites) controlled clinical study enrolling 100 subjects following a pre-specified protocol with no site enrolling more than 30 subjects. All eligible subjects providing written informed consent and meeting study eligibility criteria will receive a facet preserving decompression using the FDA cleared iO-Flex® system on label. Treatment success using the iO-Flex® System will be analyzed using a precision estimate assuming a 55% positive response rate.

In addition to baseline characteristics and procedural parameters, subject outcomes will be assessed at 6 weeks, 6-, 12-, and 24 months. The study will have an extended follow-up phase with annual follow-up contact through 5 years to evaluate retreatment for the original indication at these late time points.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (> 18 years of age)
  • Leg/buttock pain, with or without back pain
  • Grade 1 degenerative spondylolisthesis (≤25% slippage)
  • NRS pain score for leg pain of 4/10 or greater
  • ODI score of 30/100 or greater
  • Failed non-operative medical management for a period of at least 6 months
  • Confirmed clinical diagnosis of lumbar spinal stenosis
  • Confirmation of central and/or lateral recess stenosis with or without foraminal stenosis, at one level or at two adjacent levels from L2-S1, with concordant symptoms. Subjects with central and/or lateral recess stenosis and spondylolisthesis at one level, may have symptomatic central, lateral recess or foraminal stenosis treated at one adjacent level. A "below-the pedicle" pass to decompress a third segment can be completed provided laminotomies are performed at no more than 2 levels. Subjects that, following an intraoperative decision, have a 3-level laminotomy and decompression will not be considered enrolled. Confirmation of spinal stenosis is shown on MRI or CT scan with evidence of nerve root impingement (displacement or compression) by either osseous or non-osseous elements.
  • Ability to give voluntary, written informed consent to participate in this clinical investigation and ability to participate in follow up examinations and complete patient questionnaires

排除标准

  • Back pain only
  • Diagnosis of moderate to severe peripheral neuropathy such as diabetic or idiopathic peripheral neuropathy, by EMG/NCS or a Neurologist.
  • History of pathologic fractures of the vertebrae
  • Primary disc pathology; planned or incidental discectomies will NOT be excluded as long as surgeon believes the disc pathology is not the primary reason for the surgical intervention.
  • Subjects for whom removal of the midline structures is planned, likely or is the result of an intraoperative decision; every attempt should be made to spare the supraspinous, interspinous and facet capsular ligaments.
  • Significant instability of the lumbar spine as defined by ≥ 4mm translational motion between standing lateral view flexion and extension radiographs
  • Prior surgery of the lumbar spine
  • Spondylolisthesis greater than grade 1 (on a scale of 1 to 4)
  • Spondylolysis (pars fracture) at any level in the lumbar spine
  • Degenerative lumbar scoliosis with a Cobb angle of ≥ 25°
  • Vascular claudication in the lower extremities
  • Cauda equina syndrome
  • Evidence of active (systemic or local) infection at time of surgery
  • Paget's disease at involved segment or metastasis to the vertebra, osteomalacia, or other metabolic bone disease
  • Tumor in the spine or a malignant tumor except for basal cell carcinoma.
  • Prisoner or transient
  • Any significant psychological disturbance past or present, psychotic or neurotic that could impair the consent process or ability to complete subject self-report questionnaires
  • Involved in pending litigation of the spine or worker's compensation related to the back
  • Inability to communicate clearly in the English language
  • Morbid obesity (BMI > 40)
  • Pregnant, nursing, or planning on becoming pregnant.
  • History of narcotic abuse
  • Current involvement in another drug or device clinical trial
  • Uncontrolled diabetes
  • Irreversible coagulopathy or bleeding disorder (patients on anticoagulant therapy may participate. Investigators should follow routine practices for perioperative discontinuation and reinitiation of anticoagulants.)
  • Plans to relocate in the next 2 years
  • Subject unwilling to undergo a blood transfusion, if necessary

结局指标

主要结局

Oswestry Disability Index (ODI)

时间窗: 24 Months

Responder analysis

次要结局

  • Operative success(Operative (day 1))
  • Oswestry Disability Index (ODI)(6, 12, 24, 36, 48 and 60 months)
  • Numerical Rating Scale (NRS)(6, 12, 24, 36, 48 and 60 months)
  • Zurich Claudication Questionnaire (ZCQ)(6, 12, 24, 36, 48 and 60 months)
  • SF-36 Health Survey(6, 12, 24, 36, 48 and 60 months)
  • Treatment survival rate(Ongoing out to 60 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验